Centauri Therapeutics
Developing novel Alphamer® therapeutics to combat serious diseases, with a primary focus on antimicrobial resistance (AMR).
About
Technology stack
detected 2026-06-10No comments yet. Be the first to share your take.
What does Centauri Therapeutics do?
Centauri Therapeutics is a biotechnology company based in Alderley Park, UK, focused on the discovery and development of novel therapeutics for serious diseases. Leveraging its proprietary Alphamer® platform, the company develops immunotherapies that harness the body's natural immune response to fight life-threatening infections, particularly multi-drug resistant Gram-negative bacteria. The platform also has initial proof-of-concept data in oncology, expanding therapeutic options for vulnerable…
How much funding has Centauri Therapeutics raised?
Centauri Therapeutics has raised a total of $57M in funding. The most recent round on record is Series A.
Where is Centauri Therapeutics headquartered?
Centauri Therapeutics is headquartered in Oxford, England, United Kingdom.
What industry does Centauri Therapeutics operate in?
Centauri Therapeutics operates in Biotechnology, Pharmaceuticals, Drug Discovery, Antimicrobial Resistance.